10-Q/A: Amesite Inc. Amends Quarterly Report Due to Internal Control Weaknesses
Quarterly Report Amendment
Amesite Inc. has amended its quarterly report to disclose material weaknesses in its internal controls over financial reporting as of June 30, 2024.
Summary
- Amesite Inc. has filed an amendment to its quarterly report for the period ended September 30, 2024, to correct disclosures regarding internal control over financial reporting.
- The company identified material weaknesses in its internal controls as of June 30, 2024, specifically in the areas of journal entry review and approval, stock compensation expense calculation and recording, stock-based compensation classification, and deferred revenue recognition.
- The amendment includes new certifications from the CEO and CFO.
- The company's net loss for the quarter was $908,045, compared to a net loss of $890,693 for the same period last year.
- Revenue for the quarter was $11,250, a decrease from $63,333 in the same quarter of the previous year.
- The company's cash and cash equivalents totaled $1,434,753 as of September 30, 2024.
- Amesite has a history of net losses and negative cash flows and has raised concerns about its ability to continue as a going concern.
- Management plans to generate cash through financing transactions, including potential stock offerings, but these plans are subject to market conditions and are not guaranteed.
Sentiment
Score: 3
Explanation: The document reveals significant financial and operational challenges, including a substantial revenue decrease, net loss, material weaknesses in internal controls, and concerns about the company's ability to continue as a going concern. While there are some positive notes about cost reductions and AI development, the overall sentiment is negative due to the severity of the issues.
Positives
- The company is taking steps to remediate the identified material weaknesses in internal controls.
- The company has reduced operating expenses through cost reductions, including reductions in headcount and associated administrative costs.
- The company has focused new development work on delivering AI tools to markets, such as the NurseMagic app.
Negatives
- The company reported a net loss of $908,045 for the quarter.
- Revenue decreased significantly to $11,250 from $63,333 in the same quarter of the previous year.
- The company has identified material weaknesses in its internal controls over financial reporting.
- There is substantial doubt about the company's ability to continue as a going concern.
- The company has a history of net losses and negative cash flows from operating activities.
Risks
- The company's ability to continue as a going concern is uncertain due to its history of losses and negative cash flows.
- The company's plans to generate cash through financing transactions are subject to market conditions and are not guaranteed.
- The identified material weaknesses in internal controls could lead to misstatements in financial reporting.
- The company's reliance on third parties for its learning platform and other services poses a risk.
- The company faces risks related to obtaining and maintaining intellectual property protection.
- The company's financial performance is subject to various risks and uncertainties, including those related to government regulation and competition.
Future Outlook
The company plans to generate cash through financing transactions, including potential stock offerings, but these plans are subject to market conditions and are not guaranteed. The company is also focused on developing AI tools and expanding its customer base.
Management Comments
- Management believes that it may not have sufficient cash and cash equivalents to maintain the company's planned operations for the next twelve months.
- Management plans include generating cash by completing financing transactions, which may include offerings of common stock.
- Management has concluded that their plans do not alleviate substantial doubt about the company's ability to continue as a going concern.
- Management has strongly pivoted to grow the customer base while reducing risk and losses.
Industry Context
The company operates in the technology sector, specifically in the development of AI-driven solutions for education and healthcare. The company's focus on AI-powered learning programs and mobile healthcare apps aligns with current industry trends towards digital transformation and personalized solutions. However, the company's financial struggles and internal control issues highlight the challenges faced by early-stage technology companies.
Comparison to Industry Standards
- Amesite's revenue of $11,250 for the quarter is significantly lower than many established ed-tech companies, such as Coursera or 2U, which report revenues in the tens or hundreds of millions of dollars per quarter.
- The company's net loss of $908,045 is also concerning, as many established ed-tech companies are either profitable or have a clear path to profitability.
- The identification of material weaknesses in internal controls is a serious issue that needs to be addressed, as it can impact investor confidence and the reliability of financial reporting. This is not typical for publicly listed companies.
- The company's cash position of $1,434,753 is relatively low compared to other companies in the sector, raising concerns about its ability to fund operations and growth.
- The company's reliance on external financing and the uncertainty surrounding its ability to continue as a going concern are also significant concerns compared to more established competitors.
Stakeholder Impact
- Shareholders face significant risk due to the company's financial instability and internal control issues.
- Employees may be affected by potential cost-cutting measures or restructuring.
- Customers may be concerned about the company's ability to provide ongoing services.
- Creditors face increased risk due to the company's financial challenges.
Next Steps
- The company will take steps to remediate the material weaknesses in internal controls.
- The company will formalize its process and documentation for monitoring internal control over financial reporting.
- Management will continue to review and make necessary changes to the overall design of the company's internal control environment.
- The company will seek to generate cash through financing transactions, including potential stock offerings.
Key Dates
| Date | Description |
|---|---|
| November 2017 | Amesite Inc. was incorporated. |
| September 29, 2021 | The board of directors approved changes to director compensation. |
| February 15, 2023 | The company held a special meeting of stockholders to approve a reverse stock split. |
| February 21, 2023 | The one-for-twelve reverse stock split became effective. |
| May 3, 2024 | The board of directors approved an amendment to the 2018 Equity Incentive Plan. |
| June 18, 2024 | The amendment to the 2018 Plan was approved by the stockholders. |
| June 30, 2024 | Date of material weakness in internal controls over financial reporting. |
| September 30, 2024 | End of the quarterly period for the amended report. |
| August 1, 2024 | The company issued 250,000 shares of common stock to a consultant. |
| November 14, 2024 | Date of original 10-Q filing. |
| January 2, 2025 | Date of amended 10-Q/A filing. |
Keywords
internal controls, financial reporting, material weakness, going concern, revenue, net loss, stock compensation, deferred revenue, cash flow, financing, AI, NurseMagic
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.